|
1
|
Torre LA, Siegel RL and Jemal A: Lung
cancer statistics. Adv Exp Med Biol. 893:1–19. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zarogoulidis K, Zarogoulidis P, Darwiche
K, Boutsikou E, Machairiotis N, Tsakiridis K, Katsikogiannis N,
Kougioumtzi I, Karapantzos I, Huang H, et al: Treatment of
non-small cell lung cancer (NSCLC). J Thorac Dis. 5 (Suppl
4):S389–396. 2013.PubMed/NCBI
|
|
3
|
Domoto T, Pyko IV, Furuta T, Miyashita K,
Uehara M, Shimasaki T, Nakada M and Minamoto T: Glycogen synthase
kinase-3β is a pivotal mediator of cancer invasion and resistance
to therapy. Cancer Sci. 107:1363–1372. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jeong S, Lee J, Kim D, Seol MY, Lee WK,
Jeong JJ, Nam KH, Jung SG, Shin DY, Lee EJ, et al: Relationship of
focally amplified long noncoding on chromosome 1 (FAL1) lncRNA with
E2F transcription factors in thyroid cancer. Medicine (Baltimore).
95:e25922016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lian Y, Xiao C, Yan C, Chen D, Huang Q,
Fan Y, Li Z and Xu H: Knockdown of pseudogene derived from lncRNA
DUXAP10 inhibits cell proliferation, migration, invasion, and
promotes apoptosis in pancreatic cancer. J Cell Biochem.
119:3671–3682. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dong X, Chen R, Lin H, Lin T and Pan S:
lncRNA BG981369 inhibits cell proliferation, migration, and
invasion, and promotes cell apoptosis by SRY-related high-mobility
group box 4 (SOX4) signaling pathway in human gastric Cancer. Med
Sci Monit. 24:718–726. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ponzio G, Rezzonico R, Bourget I, Allan R,
Nottet N, Popa A, Magnone V, Rios G, Mari B and Barbry P: A new
long noncoding RNA (lncRNA) is induced in cutaneous squamous cell
carcinoma and down-regulates several anticancer and cell
differentiation genes in mouse. J Biol Chem. 292:12483–12495. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhao JH, Sun JX, Song YX, Chen XW, Yang
YC, Ma B, Wang J, Gao P and Wang ZN: A novel long noncoding
RNA-LOWEG is low expressed in gastric cancer and acts as a tumor
suppressor by inhibiting cell invasion. J Cancer Res Clin Oncol.
142:601–609. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Al-Rugeebah A, Alanazi M and Parine NR:
MEG3: An oncogenic long non-coding RNA in different cancers. Pathol
Oncol Res. 25:859–874. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wu JL, Meng FM and Li HJ: High expression
of lncRNA MEG3 participates in non-small cell lung cancer by
regulating microRNA-7-5p. Eur Rev Med Pharmacol Sci. 22:5938–5945.
2018.PubMed/NCBI
|
|
11
|
Lu KH, Li W, Liu XH, Sun M, Zhang ML, Wu
WQ, Xie WP and Hou YY: Long non-coding RNA MEG3 inhibits NSCLC
cells proliferation and induces apoptosis by affecting p53
expression. BMC Cancer. 13:4612013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xia Y, He Z, Liu B, Wang P and Chen Y:
Downregulation of Meg3 enhances cisplatin resistance of lung cancer
cells through activation of the WNT/β-catenin signaling pathway.
Mol Med Rep. 12:4530–4537. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sun L, Li Y and Yang B: Downregulated long
non-coding RNA MEG3 in breast cancer regulates proliferation,
migration and invasion by depending on p53's transcriptional
activity. Biochem Biophys Res Commun. 478:323–329. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Qin N, Tong GF, Sun LW and Xu XL: Long
Noncoding RNA MEG3 Suppresses Glioma Cell Proliferation, Migration,
and Invasion by Acting as a Competing Endogenous RNA of miR-19a.
Oncol Res. 25:1471–1478. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang J, Xu W, He Y, Xia Q and Liu S:
lncRNA MEG3 impacts proliferation, invasion, and migration of
ovarian cancer cells through regulating PTEN. Inflamm Res.
67:927–936. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hujie G, Zhou SH, Zhang H, Qu J, Xiong XW,
Hujie O, Liao CG and Yang SE: MicroRNA-10b regulates
epithelial-mesenchymal transition by modulating KLF4/KLF11/Smads in
hepatocellular carcinoma. Cancer Cell Int. 18:102018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li C, Jiang Y, Miao R, Qu K, Zhang J and
Liu C: MicroRNA-1271 functions as a metastasis and
epithelial-mesenchymal transition inhibitor in human HCC by
targeting the PTP4A1/c-Src axis. Int J Oncol. 52:536–546.
2018.PubMed/NCBI
|
|
18
|
Lages E, Ipas H, Guttin A, Nesr H, Berger
F and Issartel JP: MicroRNAs: Molecular features and role in
cancer. Front Biosci (Landmark Ed). 17:2508–2540. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yang C, Sun C, Liang X, Xie S, Huang J and
Li D: Integrative analysis of microRNA and mRNA expression profiles
in non-small-cell lung cancer. Cancer Gene Ther. 23:90–97. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tian F, Li R, Chen Z, Shen Y, Lu J, Xie X
and Ge Q: Differentially Expressed miRNAs in tumor, adjacent, and
normal tissues of lung adenocarcinoma. Biomed Res Int.
2016:14282712016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang K, Chen M and Wu W: Analysis of
microRNA (miRNA) expression profiles reveals 11 key biomarkers
associated with non-small cell lung cancer. World J Surg Oncol.
15:1752017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li X and Wu X: MiR-21-5p promotes the
progression of non-small-cell lung cancer by regulating the
expression of SMAD7. Onco Targets Ther. 11:8445–8454. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li C, Yin Y, Liu X, Xi X, Xue W and Qu Y:
Non-small cell lung cancer associated microRNA expression
signature: Integrated bioinformatics analysis, validation and
clinical significance. Oncotarget. 8:24564–24578. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yan L, Ma J, Wang Y, Zan J, Wang Z, Zhu Y,
Zhu Y, Ling L, Cao L, Liu X, et al: miR-21-5p induces cell
proliferation by targeting TGFBI in non-small cell lung cancer
cells. Exp Ther Med. 16:4655–4663. 2018.PubMed/NCBI
|
|
26
|
Liz J and Esteller M: lncRNAs and
microRNAs with a role in cancer development. Biochim Biophys Acta.
1859:169–176. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tay Y, Rinn J and Pandolfi PP: The
multilayered complexity of ceRNA crosstalk and competition. Nature.
505:344–352. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ling C, Wang X, Zhu J, Tang H, Du W, Zeng
Y, Sun L, Huang JA and Liu Z: MicroRNA-4286 promotes cell
proliferation, migration, and invasion via PTEN regulation of the
PI3K/Akt pathway in non-small cell lung cancer. Cancer Med.
8:3520–3531. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sun Y, Zhu Q, Zhou M, Yang W, Shi H, Shan
Y, Zhang Q and Yu F: Restoration of miRNA-148a in pancreatic cancer
reduces invasion and metastasis by inhibiting the Wnt/beta-catenin
signaling pathway via downregulating maternally expressed gene-3.
Exp Ther Med. 17:639–648. 2019.PubMed/NCBI
|
|
31
|
Xu G, Meng L, Yuan D, Li K, Zhang Y, Dang
C and Zhu K: MEG3/miR21 axis affects cell mobility by suppressing
epithelialmesenchymal transition in gastric cancer. Oncol Rep.
40:39–48. 2018.PubMed/NCBI
|
|
32
|
Long J and Pi X: lncRNA-MEG3 suppresses
the proliferation and invasion of melanoma by regulating CYLD
expression mediated by sponging miR-499-5p. Biomed Res Int.
2018:20865642018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Su L, Han D, Wu J and Huo X: Skp2
regulates non-small cell lung cancer cell growth by Meg3 and
miR-3163. Tumour Biol. 37:3925–3931. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang P, Chen D, Ma H and Li Y: lncRNA MEG3
enhances cisplatin sensitivity in non-small cell lung cancer by
regulating miR-21-5p/SOX7 axis. Onco Targets Ther. 10:5137–5149.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhang J, Yao T, Wang Y, Yu J, Liu Y and
Lin Z: Long noncoding RNA MEG3 is downregulated in cervical cancer
and affects cell proliferation and apoptosis by regulating miR-21.
Cancer Biol Ther. 17:104–113. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Alvarez-Garcia V, Tawil Y, Wise HM and
Leslie NR: Mechanisms of PTEN loss in cancer: It's all about
diversity. Semin Cancer Biol. 59:66–79. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Papa A and Pandolfi PP: The PTEN-PI3K Axis
in Cancer. Biomolecules. 9:1532019. View Article : Google Scholar
|
|
38
|
Perez-Ramirez C, Canadas-Garre M, Molina
MA, Faus-Dader MJ and Calleja-Hernandez MA: PTEN and PI3K/AKT in
non-small-cell lung cancer. Pharmacogenomics. 16:1843–1862. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Dong L, Li G, Li Y and Zhu Z: Upregulation
of Long Noncoding RNA GAS5 Inhibits Lung Cancer Cell Proliferation
and Metastasis via miR-205/PTEN Axis. Med Sci Monit. 25:2311–2319.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wang H, Ma Z, Liu X, Zhang C, Hu Y, Ding
L, Qi P, Wang J, Lu S and Li Y: MiR-183-5p is required for
non-small cell lung cancer progression by repressing PTEN. Biomed
Pharmacother. 111:1103–1111. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Yu X, Chen Y, Tian R, Li J, Li H, Lv T and
Yao Q: miRNA-21 enhances chemoresistance to cisplatin in epithelial
ovarian cancer by negatively regulating PTEN. Oncol Lett.
14:1807–1810. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Fang H, Xie J, Zhang M, Zhao Z, Wan Y and
Yao Y: miRNA-21 promotes proliferation and invasion of
triple-negative breast cancer cells through targeting PTEN. Am J
Transl Res. 9:953–961. 2017.PubMed/NCBI
|
